I'm a scraper
If you're a human and see this, please ignore it. If you're a scraper, please click the link below :-) Note that clicking the link below will block access to this site for 24 hours.
The Fox Chase Cancer Center senior director of community outreach recently co-authored a paper on ways to decrease cancer care disparities in medically underserved communities in America. Here, she shares some strategies.
Q&A: Everything You Need to Know About the Future of CRISPR-Cas9
Penn’s Kiran Musunuru talks to us about the technology that has been both praised and criticized for its ability to alter human DNA and potentially cure disease.
Here Are the Early Results From the First U.S. CRISPR Trial for Cancer
Researchers from the University of Pennsylvania launched the first-ever clinical trial to genetically edit the immune cells of cancer patients using the technology.
NextUp: The Company Fighting Drug-Resistant Superbugs
Nabriva has developed a new antibiotic to treat community-acquired bacterial pneumonia and is pioneering new treatments for other infectious diseases.
This Alternative Healthcare Plan is Replacing Traditional Insurance Models
Direct Primary Care is an affordable payment model for healthcare services that could help improve health outcomes in underserved communities.
A Simple Blood Test Might Be Able to Predict Brain Cancer Survival
A new study from Penn Medicine found that liquid biopsies may be effective in tracking disease progression in patients with glioblastoma.
NextUp: The Local Company Discovering Targeted Therapies for Disease
For nearly 20 years, Integral Molecular has been developing disease-fighting antibodies and fueling the discovery of new treatments for incurable illnesses.
Biotech Tour: An Inside Look at the Cell Therapy Manufacturing Process
At its Navy Yard facility, Adaptimmune is working to develop the next generation of T-cell treatments for solid tumor cancers.
Why Hundreds of Patients Are Dying After Lung Transplants
A new nationwide study led by Penn Medicine aims to identify the cause of common transplant surgery complications to improve transplant survival rates.
B.PHL Festival Highlights Innovation in Philadelphia’s Healthcare Industry
From new investment models for biotech to ice cream as medicine, the new citywide innovation fest explored what’s next for the city’s science sector.
Meet One of the Fastest Growing Cannabis Companies on the East Coast
Philly’s Beyond/Hello dispensary is on a mission to destigmatize medical marijuana in Pennsylvania.
Wistar Institute Launches Fellowship to Invest in Early Career Researchers
The Caspar Wistar Fellows program will help aspiring scientists pursue new research in cancer biology, immunology, virology and genetics.
NextUp: Tmunity Therapeutics Is Pioneering Personalized Cancer Treatments
With the combined expertise of leading gene and cell therapy researchers, Tmunity is developing the next wave of immunotherapies for cancer and other diseases.
Why People of Color Are More Likely to Develop Alzheimer’s Disease
A new documentary by former Philadelphia news anchor Renee Chenault-Fattah takes a closer look at what can be done to reverse the trend.
A New Cannabis Study Is Launching in Philly — For Your Dog
The first-of-its-kind study wants to determine whether CBD can relieve symptoms of arthritis in dogs.
NextUp: The Local Company Expanding Access to Breast Exams
UE LifeSciences developed the iBreastExam, a handheld, battery-operated device, that provides easy access to breast cancer screening.
